S Derry

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi Appetite suppressants and valvular heart disease - a systematic review
    Yoon K Loke
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, OX2 6HE, United Kingdom
    BMC Clin Pharmacol 2:6. 2002
  2. ncbi Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
    S Derry
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford, OX2 6HE, United Kingdom
    BMC Med Res Methodol 1:7. 2001
  3. ncbi Reporting of adverse drug reactions in randomised controlled trials - a systematic survey
    Y K Loke
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, OX2 6HE, England
    BMC Clin Pharmacol 1:3. 2001
  4. ncbi Acute pain: combination treatments and how we measure their efficacy
    H J McQuay
    Pain Research and Nuffield Department of Anaesthetics, University of Oxford, The Churchill, Headington, Oxford OX3 7LJ, UK
    Br J Anaesth 101:69-76. 2008
  5. ncbi Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies
    S Straube
    Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford Radcliffe Hospital, The Churchill, Headington, Oxford OX3 7LJ, UK
    Acta Anaesthesiol Scand 49:601-13. 2005
  6. ncbi Evaluation and registration of adverse events in clinical drug trials in migraine
    P Tfelt-Hansen
    Danish Headache Centre, Department of Neurology, University of Copenhagen, Glostrup Hospital, Copenhagen, Denmark
    Cephalalgia 28:683-8. 2008

Detail Information

Publications6

  1. ncbi Appetite suppressants and valvular heart disease - a systematic review
    Yoon K Loke
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, OX2 6HE, United Kingdom
    BMC Clin Pharmacol 2:6. 2002
    ..Our objective was to systematically assess the risk of valvular heart disease with appetite suppressants...
  2. ncbi Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
    S Derry
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, Oxford, OX2 6HE, United Kingdom
    BMC Med Res Methodol 1:7. 2001
    ..We have determined how often automated search methods, using indexing terms and/or textwords in the title or abstract, would fail to retrieve trials with adverse effects data...
  3. ncbi Reporting of adverse drug reactions in randomised controlled trials - a systematic survey
    Y K Loke
    Department of Clinical Pharmacology, University of Oxford, Radcliffe Infirmary, OX2 6HE, England
    BMC Clin Pharmacol 1:3. 2001
    ..However, some researchers have found numerous deficiencies in trial reports of adverse effects. We sought to confirm these findings by evaluating trials of drug therapy published in seven eminent medical journals in 1997...
  4. ncbi Acute pain: combination treatments and how we measure their efficacy
    H J McQuay
    Pain Research and Nuffield Department of Anaesthetics, University of Oxford, The Churchill, Headington, Oxford OX3 7LJ, UK
    Br J Anaesth 101:69-76. 2008
    ....
  5. ncbi Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies
    S Straube
    Pain Research and Nuffield Department of Anaesthetics, University of Oxford, Oxford Radcliffe Hospital, The Churchill, Headington, Oxford OX3 7LJ, UK
    Acta Anaesthesiol Scand 49:601-13. 2005
    ..Effects on postoperative nausea and vomiting remain uncertain, as do those on recovery from surgery or economic benefit. Future trials should be larger and more pragmatic in nature...
  6. ncbi Evaluation and registration of adverse events in clinical drug trials in migraine
    P Tfelt-Hansen
    Danish Headache Centre, Department of Neurology, University of Copenhagen, Glostrup Hospital, Copenhagen, Denmark
    Cephalalgia 28:683-8. 2008
    ..Tolerability may be indirectly assessed using measures of general well-being and eight such tools are presented. Finally, recommendations for reporting of adverse events are given...